JPH0252220B2 - - Google Patents
Info
- Publication number
- JPH0252220B2 JPH0252220B2 JP58503487A JP50348783A JPH0252220B2 JP H0252220 B2 JPH0252220 B2 JP H0252220B2 JP 58503487 A JP58503487 A JP 58503487A JP 50348783 A JP50348783 A JP 50348783A JP H0252220 B2 JPH0252220 B2 JP H0252220B2
- Authority
- JP
- Japan
- Prior art keywords
- membrane
- red blood
- blood cells
- strip
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000003743 erythrocyte Anatomy 0.000 description 50
- 239000012528 membrane Substances 0.000 description 49
- 210000004369 blood Anatomy 0.000 description 48
- 239000008280 blood Substances 0.000 description 48
- 239000011148 porous material Substances 0.000 description 33
- 230000002745 absorbent Effects 0.000 description 29
- 239000002250 absorbent Substances 0.000 description 29
- 239000012530 fluid Substances 0.000 description 26
- 238000001914 filtration Methods 0.000 description 23
- 238000010521 absorption reaction Methods 0.000 description 21
- 238000000034 method Methods 0.000 description 19
- 238000005534 hematocrit Methods 0.000 description 10
- 208000007056 sickle cell anemia Diseases 0.000 description 8
- 238000005259 measurement Methods 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 238000011085 pressure filtration Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000009601 hereditary spherocytosis Diseases 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US432635DEEDK | 1982-10-04 | ||
| PCT/US1983/001544 WO1984001429A1 (en) | 1982-10-04 | 1983-10-04 | Process and device for erythrocyte deformation determination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59501961A JPS59501961A (ja) | 1984-11-22 |
| JPH0252220B2 true JPH0252220B2 (enrdf_load_html_response) | 1990-11-09 |
Family
ID=22175473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58503487A Granted JPS59501961A (ja) | 1982-10-04 | 1983-10-04 | 赤血球濾過装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59501961A (enrdf_load_html_response) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07272543A (ja) * | 1994-01-03 | 1995-10-20 | Internatl Business Mach Corp <Ibm> | 側縁部を補強したリボン・ケーブル |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0287651B1 (en) * | 1986-10-17 | 1992-09-09 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Method and apparatus for estimating hematocrit in a blood constituent processing system |
-
1983
- 1983-10-04 JP JP58503487A patent/JPS59501961A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07272543A (ja) * | 1994-01-03 | 1995-10-20 | Internatl Business Mach Corp <Ibm> | 側縁部を補強したリボン・ケーブル |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59501961A (ja) | 1984-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4491012A (en) | Method for measuring erythrocyte deformability | |
| Lonnroth et al. | A microdialysis method allowing characterization of intercellular water space in humans | |
| US3552929A (en) | Diagnosis means | |
| Buchan | Evaluation and modification of whole blood filtration in the measurement of erythrocyte deformability in pregnancy and the newborn | |
| Kikuchi et al. | Improved filtration method for red cell deformability measurement | |
| EP0390984B1 (en) | Oral fluid collection article | |
| Koutsouris et al. | Determination of erythrocyte transit times through micropores. I-Basic operational principles | |
| Dormandy | Red Cell Deformability and Filterability: Proceedings of the second workshop held in London, 23 and 24 September 1982 under the auspices of The Royal Society of Medicine and the Groupe de Travail sur la Filtration Erythrocytaire | |
| JPH07502118A (ja) | 関連血液パラメータの定量方法と定量装置 | |
| US10488424B2 (en) | Devices and methods for analyzing a blood coagulation property | |
| US7115421B2 (en) | Method and device for measurement of hematocrit | |
| US7908906B2 (en) | Fluidic test apparatus and method | |
| JPH0252220B2 (enrdf_load_html_response) | ||
| US11525801B2 (en) | Strip structure for measuring potassium ions | |
| SWANK et al. | Blood cell aggregation and screen filtration pressure | |
| US4402216A (en) | Erythrocyte deformability monitor | |
| Tamblyn et al. | Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis | |
| Leblond et al. | Evaluation of a simplified filtration technique for the routine measurement of erythrocyte deformability | |
| Lucas et al. | Comparison of silver and polycarbonate membranes for measurement of erythrocyte filterability | |
| Johnsson et al. | Studies on red cell flexibility in spherocytosis using a polycarbonate membrane filtration method | |
| Waugh et al. | Shear rate-dependence of leukocyte cytoplasmic viscosity | |
| Athanassiou et al. | Deformability of the erythrocyte membrane in patients with myelodysplastic syndromes | |
| SU1174855A1 (ru) | Способ определени неспецифической иммунологической активности полиморфно дерных лейкоцитов периферической крови | |
| NAOASAWA et al. | Graphic analysis of osmotic fragility of erythrocytes | |
| Ito et al. | Continuous flow method for determination of erythrocyte osmotic fragility |